July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Nitric Oxide Induces Changes in the Cytoskeleton and ECM of TGFβ2-treated Trabecular Meshwork and Schlemm’s canal cells
Author Affiliations & Notes
  • Karen Yud Torrejon
    Glauconix Biosciences, Albany, New York, United States
  • Ellen L Papke
    Glauconix Biosciences, Albany, New York, United States
  • Andrea Unser
    Glauconix Biosciences, Albany, New York, United States
  • Matthew Kerr
    Nanoscale Engineering, State University of New York Polytechnic Institute, Albany, New York, United States
  • W Daniel Stamer
    Department of Ophthalmology, Duke University, Durham, North Carolina, United States
  • Feryan Ahmed
    Glauconix Biosciences, Albany, New York, United States
  • Footnotes
    Commercial Relationships   Karen Torrejon, Glauconix Biosciences Inc. (E); Ellen Papke, Glauconix Biosciences (E); Andrea Unser, Glauconix Biosciences (E); Matthew Kerr, None; W Daniel Stamer, Glauconix Biosciences (C); Feryan Ahmed, Glauconix Biosciences (E)
  • Footnotes
    Support  NSF SBIR II 1660131
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 4708. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Karen Yud Torrejon, Ellen L Papke, Andrea Unser, Matthew Kerr, W Daniel Stamer, Feryan Ahmed; Nitric Oxide Induces Changes in the Cytoskeleton and ECM of TGFβ2-treated Trabecular Meshwork and Schlemm’s canal cells. Invest. Ophthalmol. Vis. Sci. 2018;59(9):4708.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : Nitric oxide synthase (NOS) and thereby the production of nitric oxide (NO) has been shown to increase aqueous humor outflow facility and subsequently lower intraocular pressure (IOP). The binding of NO to soluble guanylate cyclase (sGC) initiates a cascade of events such as the promotion of vasodilation, which could therefore increase outflow within the conventional outflow pathway involving both the trabecular meshwork and Schlemm’s canal. Using a 3D bioengineered construct of the human conventional outflow tract, we studied the effect of NO donating compounds on actin cytoskeleton and proteins that have been linked to glaucomatous conventional outflow tract.

Methods : 3D conventional outflow tract constructs, comprised of HTM, HSC cells and their associated ECM, were treated with TGFb-2 (2.5 ng/mL) for at 9 days to induce a glaucomatous state. These constructs were then exposed to two different NO-donating compounds, SNP (100µM) or DETA-NO (100µM) for 48 hrs. Cells were stained with phalloidin-488 and the changes in actin cytoskeleton were analyzed by confocal microscopy. The protein and gene expression of a-smooth muscle actin, fibronectin, and collagen type IV (col-IV) were analyzed by western blot and qPCR. Statistical significance was determined using one-way ANOVA followed by Bonferroni post-tests.

Results : Immunocytochemical analysis showed pronounced changes in the actin cytoskeleton of the cells after SNP and DETA-NO treatments. Both NO-donating agents relaxed the cells and induced actin depolymerization demonstrated by less pronounced and shorter F-actin fibers. Western blot analysis and immunocytochemistry demonstrated a significant decrease in expression of a- smooth muscle actin in both, SNP and DETA-NO treated 3D constructs (p<0.01 and p<0.05, respectively). Furthermore, fibronectin and col-IV protein and gene expression was significantly lowered (p<0.01 and 0.05, respectively). Confocal imaging further confirmed the decreased expression of fibronectin and col-IV in the NO-treated samples.

Conclusions : We report that NO induce changes in the actin cytoskeleton and ECM by decreasing F-actin, a- smooth muscle actin and ECM proteins, fibronectin and col-IV, expression. Decrease in expression of cytoskeletal and ECM proteins suggests a potential mechanism by which NO-donating agents sustain IOP-lowering effect through the conventional outflow pathway.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.